Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3623
-0.0227 (-5.90%)
At close: Jun 27, 2025, 4:00 PM
0.3797
+0.0174 (4.80%)
After-hours: Jun 27, 2025, 7:56 PM EDT
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $21.47 million as of June 27, 2025. Its market cap has decreased by -89.61% in one year.
Market Cap
21.47M
Enterprise Value
-27.94M
1-Year Change
-89.61%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $21.47M, a decrease of -94.12%. That is a compound annual growth rate of -50.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 22.81M | -31.43% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |